Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$291K Sell
1,423
-713
-33% -$153K 0.02% 399
2021
Q2
$441K Buy
+2,136
New +$430K 0.02% 365

Other funds holding STE

BBVA USA's STE Position: Q3 2021 in Review

BBVA USA reduced its Steris (STE) stake by 33% in Q3 2021, selling an estimated $153K and leaving 1,423 shares worth $291K. The position accounts for 0.02% of the portfolio, ranked #399.

BBVA USA first reported a position in STE in Q2 2021 and has held it in 2 quarters since. The position peaked at $441K in Q2 2021. 628 funds tracked by Wall St. Rank hold STE as of Q3 2021.

  • BBVA USA held 1,423 shares of Steris worth $291K as of Q3 2021.
  • BBVA USA sold 713 Steris shares in Q3 2021, an estimated $153K.
  • Steris made up 0.02% of BBVA USA's portfolio in Q3 2021, its #399 holding.
  • BBVA USA first reported a position in Steris in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Steris position peaked at $441K in Q2 2021.
  • 628 funds tracked by Wall St. Rank held Steris as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.